Income Statement Guided Therapeutics, Inc.

Stocks

GTHP

US40171F5017

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 04:32:34 10/09/26 am AEST			5-day change	1st Jan Change
0.2500 ^USD	+25.00%		+25.00%	-53.70%

10/09	Guided Therapeutics, Inc. and Türkiye Ministry of Health Reach Collaborative Agreement for Primary Screening Test for Cervical Cancer	CI
14/08	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

679ecf9ff9.KVyYi-G5gHr4Lnfr7aYLwtTuMx_e5d6XGEt6szH2H8Q.aCvBw9GN-QnBSSaDoOJ8sJGsaymvke7lfRQx7AWHLvVROPTijtv6IJ10Ng

Published financial data: GUIDED THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	81K	13K	98K	7K	767K
Total Revenues	81K	13K	98K	7K	767K
Cost of Goods Sold, Total	61K	81K	62K	5K	196K
Gross Profit	20K	-68K	36K	2K	571K
Selling General & Admin Expenses, Total	2.31M	3.19M	3.26M	1.58M	2.47M
R&D Expenses	69K	77K	228K	526K	469K
Other Operating Expenses, Total	2.38M	3.26M	3.49M	2.11M	2.94M
Operating Income	-2.36M	-3.33M	-3.46M	-2.11M	-2.37M
Interest Expense, Total	-1.15M	-582K	-278K	-381K	-617K
Interest And Investment Income	-	-	6K	3K	-
Net Interest Expenses	-1.15M	-582K	-272K	-378K	-617K
Other Non Operating Income (Expenses)	864K	43K	44K	0	230K
EBT, Excl. Unusual Items	-2.65M	-3.87M	-3.68M	-2.49M	-2.76M
Other Unusual Items	578K	-469K	196K	69K	-437K
EBT, Incl. Unusual Items	-2.07M	-4.34M	-3.49M	-2.42M	-3.2M
Earnings From Continuing Operations	-2.07M	-4.34M	-3.49M	-2.42M	-3.2M
Net Income to Company	-2.07M	-4.34M	-3.49M	-2.42M	-3.2M
Net Income - (IS)	-2.07M	-4.34M	-3.49M	-2.42M	-3.2M
Preferred Dividend and Other Adjustments	361K	631K	270K	174K	150K
Net Income to Common Incl Extra Items	-2.43M	-4.97M	-3.76M	-2.59M	-3.35M
Net Income to Common Excl. Extra Items	-2.43M	-4.97M	-3.76M	-2.59M	-3.35M
Per Share Items
Net EPS - Basic	-0.18	-0.15	-0.07	-0.05	-0.04
Basic EPS - Continuing Operations	-0.18	-0.15	-0.07	-0.05	-0.04
Basic Weighted Average Shares Outstanding	13.38M	32.5M	51.13M	57.34M	78.41M
Net EPS - Diluted	-0.18	-0.15	-0.07	-0.05	-0.04
Diluted EPS - Continuing Operations	-0.18	-0.15	-0.07	-0.05	-0.04
Diluted Weighted Average Shares Outstanding	13.38M	32.5M	51.13M	57.34M	78.41M
Normalized Basic EPS	-0.12	-0.07	-0.05	-0.03	-0.02
Normalized Diluted EPS	-0.12	-0.07	-0.05	-0.03	-0.02
Supplemental Items
EBITDA	-2.36M	-3.33M	-3.45M	-2.1M	-2.36M
EBITA	-2.36M	-3.33M	-3.46M	-2.11M	-2.37M
EBIT	-2.36M	-3.33M	-3.46M	-2.11M	-2.37M
EBITDAR	-	-	-	-	-2.35M
Normalized Net Income	-1.66M	-2.42M	-2.3M	-1.55M	-1.72M
Supplemental Operating Expense Items
Selling and Marketing Expenses	141K	181K	268K	287K	169K
General and Administrative Expenses	2.17M	3.01M	3M	1.3M	2.29M
Research And Development Expense From Footnotes	69K	77K	228K	526K	469K
Net Rental Expense, Total	-	-	-	-	12.9K
Imputed Operating Lease Interest Expense	-	-	-	-	24.98K
Imputed Operating Lease Depreciation	-	-	-	-	-12.08K
Stock-Based Comp., G&A Exp. (Total)	664K	1.2M	739K	-	297K
Stock-Based Comp., Other (Total)	228K	176K	1.07M	120K	80.19K
Total Stock-Based Compensation	892K	1.38M	1.81M	120K	377K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	643K	2.31M	591K	388K	63K
Total Cash And Short Term Investments	643K	2.31M	591K	388K	63K
Accounts Receivable, Total	46K	6K	7K	3K	4K
Total Receivables	46K	6K	7K	3K	4K
Inventory	571K	548K	632K	633K	448K
Other Current Assets, Total	377K	137K	163K	173K	90K
Total Current Assets	1.64M	3M	1.39M	1.2M	605K
Gross Property Plant And Equipment	2.13M	2.1M	1.84M	1.76M	2.3M
Accumulated Depreciation	-1.75M	-1.75M	-1.58M	-1.59M	-1.6M
Net Property Plant And Equipment	386K	345K	259K	164K	702K
Other Long-Term Assets, Total	17K	17K	17K	17K	17K
Total Assets	2.04M	3.37M	1.67M	1.38M	1.32M
Liabilities
Accounts Payable, Total	2.45M	2.22M	2.02M	2.13M	2.45M
Accrued Expenses, Total	1.07M	980K	742K	784K	1.52M
Short-term Borrowings	824K	288K	59K	139K	1.2M
Current Portion of Long-Term Debt	249K	521K	1.24M	1.8M	1M
Current Portion of Leases	67K	79K	91K	106K	45K
Unearned Revenue Current, Total	337K	509K	424K	849K	189K
Other Current Liabilities	700K	267K	228K	345K	232K
Total Current Liabilities	5.69M	4.87M	4.81M	6.16M	6.64M
Long-Term Debt	1.43M	1.13M	511K	63K	43K
Long-Term Leases	325K	246K	155K	49K	651K
Other Non Current Liabilities	32K	5K	-	-	-
Total Liabilities	7.48M	6.25M	5.48M	6.27M	7.33M
Preferred Stock Convertible	6.87M	3.08M	3.02M	3M	1.62M
Total Preferred Equity	6.87M	3.08M	3.02M	3M	1.62M
Common Stock, Total	3.4M	3.44M	3.44M	3.45M	3.47M
Additional Paid In Capital	127M	138M	141M	143M	146M
Retained Earnings	-142M	-147M	-151M	-154M	-157M
Treasury Stock	-132K	-132K	-132K	-132K	-132K
Total Common Equity	-12.32M	-5.96M	-6.83M	-7.89M	-7.62M
Total Equity	-5.44M	-2.88M	-3.81M	-4.89M	-6.01M
Total Liabilities And Equity	2.04M	3.37M	1.67M	1.38M	1.32M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	22.06M	50.51M	55.61M	77.97M	96.35M
ECS Total Common Shares Outstanding	13.67M	48.6M	54.11M	65.13M	86.15M
Book Value / Share	-0.9	-0.12	-0.13	-0.12	-0.09
Tangible Book Value	-12.32M	-5.96M	-6.83M	-7.89M	-7.62M
Tangible Book Value Per Share	-0.9	-0.12	-0.13	-0.12	-0.09
Total Debt	2.9M	2.26M	2.06M	2.16M	2.94M
Net Debt	2.26M	-50K	1.47M	1.77M	2.88M
Debt Equivalent Oper. Leases	-	-	-	-	103K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.26M	1.26M	1.36M	1.36M	1.19M
Inventories - Work In Process, Total	69K	68K	46K	46K	71K
Inventories - Finished Goods, Total	32K	38K	44K	43K	4K
Machinery, Total	1.09M	1.12M	968K	968K	970K
Full Time Employees	5	6	4	4	3
Accumulated Allowance for Doubtful Accounts (Supple)	126K	48K	2K	500	4K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-2.07M	-4.34M	-3.49M	-2.42M	-3.2M
Depreciation & Amortization - CF	83K	72K	85K	95K	107K
Depreciation & Amortization, Total	83K	72K	85K	95K	107K
Amortization of Deferred Charges, Total - (CF)	328K	143K	130K	93K	244K
Stock-Based Compensation (CF)	228K	176K	1.81M	120K	377K
Provision and Write-off of Bad Debts	-	23K	2K	-	6K
Other Operating Activities, Total	-239K	1.9M	-175K	-13K	405K
Change In Accounts Receivable	-22K	16K	-3K	6K	-7K
Change In Inventories	33K	-58K	-84K	-1K	185K
Change In Accounts Payable	136K	123K	43K	545K	1.36M
Change in Unearned Revenues	296K	172K	-85K	425K	-660K
Change in Other Net Operating Assets	-365K	296K	24K	28K	108K
Cash from Operations	-1.59M	-1.48M	-1.75M	-1.12M	-1.07M
Capital Expenditure	-14K	-31K	-	-	-2K
Cash from Investing	-14K	-31K	-	-	-2K
Short Term Debt Issued, Total	-	-	-	75K	-
Long-Term Debt Issued, Total	1.25M	-	-	512K	748K
Total Debt Issued	1.25M	-	-	587K	748K
Short Term Debt Repaid, Total	-1.47M	-540K	-412K	-39K	-
Long-Term Debt Repaid, Total	-	-	-	-438K	-540K
Total Debt Repaid	-1.47M	-540K	-412K	-477K	-540K
Issuance of Common Stock	-	1.92M	436K	835K	567K
Issuance of Preferred Stock	2.1M	-	-	-	-
Repurchase of Preferred Stock	-125K	-	-	-	-
Other Financing Activities, Total	312K	1.8M	-	-29K	-30K
Cash from Financing	2.07M	3.18M	24K	916K	745K
Net Change in Cash	461K	1.67M	-1.72M	-203K	-325K
Supplemental Items
Cash Interest Paid	557K	149K	107K	51K	61K
Levered Free Cash Flow	-2.2M	-1.15M	-988K	-662K	-592K
Unlevered Free Cash Flow	-1.81M	-931K	-945K	-516K	-450K
Change In Net Working Capital	1.3M	270K	675K	-586K	-550K
Net Debt Issued / Repaid	-220K	-540K	-412K	110K	208K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-87.09	-77.07	-85.82	-86.48	-109.73
Return on Total Capital	32.82	131.59	182.49	57.58	51.15
Return On Equity %	25.4	104.25	104.32	55.6	58.67
Return on Common Equity	18.78	54.4	58.78	35.22	43.14
Margin Analysis
Gross Profit Margin %	24.69	-523.08	36.73	28.57	74.45
SG&A Margin	2.86K	24.52K	3.33K	22.63K	322.56
EBITDA Margin %	-2.91K	-25.61K	-3.52K	-29.99K	-307.95
EBITA Margin %	-2.92K	-25.64K	-3.53K	-30.11K	-309.26
EBIT Margin %	-2.92K	-25.64K	-3.53K	-30.11K	-309.26
Income From Continuing Operations Margin %	-2.56K	-33.39K	-3.56K	-34.53K	-416.69
Net Income Margin %	-2.56K	-33.39K	-3.56K	-34.53K	-416.69
Net Avail. For Common Margin %	-3K	-38.25K	-3.84K	-37.01K	-436.25
Normalized Net Income Margin	-2.04K	-18.62K	-2.35K	-22.2K	-224.82
Levered Free Cash Flow Margin	-2.72K	-8.86K	-1.01K	-9.45K	-77.2
Unlevered Free Cash Flow Margin	-2.24K	-7.16K	-963.9	-7.38K	-58.74
Asset Turnover
Asset Turnover	0.05	0	0.04	0	0.57
Fixed Assets Turnover	0.19	0.04	0.32	0.03	1.77
Receivables Turnover (Average Receivables)	2.31	0.5	15.08	1.4	219.14
Inventory Turnover (Average Inventory)	0.1	0.14	0.11	0.01	0.36
Short Term Liquidity
Current Ratio	0.29	0.62	0.29	0.19	0.09
Quick Ratio	0.12	0.48	0.12	0.06	0.01
Operating Cash Flow to Current Liabilities	-0.28	-0.3	-0.36	-0.18	-0.16
Days Sales Outstanding (Average Receivables)	157.72	730	24.21	261.43	1.67
Days Outstanding Inventory (Average Inventory)	3.52K	2.52K	3.47K	46.3K	1.01K
Average Days Payable Outstanding	33.69K	14.71K	5.31K	127K	75.94K
Cash Conversion Cycle (Average Days)	-30.01K	-11.46K	-1.81K	-80.11K	-74.93K
Long Term Solvency
Total Debt/Equity	-53.24	-78.49	-54.07	-44.16	-48.93
Total Debt / Total Capital	-113.86	-365	-117.73	-79.08	-95.83
LT Debt/Equity	-32.3	-47.69	-17.5	-2.29	-11.56
Long-Term Debt / Total Capital	-69.09	-221.77	-38.1	-4.1	-22.63
Total Liabilities / Total Assets	366.91	185.65	328.04	454.79	553.63
EBIT / Interest Expense	-2.05	-5.73	-12.44	-5.53	-3.84
EBITDA / Interest Expense	-2.05	-5.72	-12.4	-5.51	-3.81
(EBITDA - Capex) / Interest Expense	-2.07	-5.77	-12.4	-5.51	-3.81
Total Debt / EBITDA	-1.23	-0.68	-0.6	-1.03	-1.25
Net Debt / EBITDA	-0.96	0.02	-0.43	-0.84	-1.22
Total Debt / (EBITDA - Capex)	-1.22	-0.67	-0.6	-1.03	-1.25
Net Debt / (EBITDA - Capex)	-0.95	0.01	-0.43	-0.84	-1.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-20.59	-83.95	653.85	-92.86	10.86K
Gross Profit, 1 Yr. Growth %	-86.01	-440	-152.94	-94.44	28.45K
EBITDA, 1 Yr. Growth %	129	41	3.57	-22.51	12.53
EBITA, 1 Yr. Growth %	124.52	41.11	3.72	-22.44	12.52
EBIT, 1 Yr. Growth %	124.52	41.11	3.72	-22.44	12.52
Earnings From Cont. Operations, 1 Yr. Growth %	641.94	109.71	-19.63	-30.73	32.23
Net Income, 1 Yr. Growth %	641.94	109.71	-19.63	-30.73	32.23
Normalized Net Income, 1 Yr. Growth %	-15.68K	46.22	-4.83	-15.61	10.98
Diluted EPS Before Extra, 1 Yr. Growth %	354.32	-15.83	-51.94	-31.99	-14.66
Accounts Receivable, 1 Yr. Growth %	91.67	-86.96	16.67	-57.14	33.33
Inventory, 1 Yr. Growth %	-5.62	-4.03	15.33	0.16	-29.23
Net Property, Plant and Equip., 1 Yr. Growth %	-14.98	-10.62	-24.93	-36.68	328.05
Total Assets, 1 Yr. Growth %	51.11	65	-50.42	-17.44	-3.92
Tangible Book Value, 1 Yr. Growth %	-9.28	-51.57	14.45	15.56	-3.35
Common Equity, 1 Yr. Growth %	-9.28	-51.57	14.45	15.56	-3.35
Cash From Operations, 1 Yr. Growth %	-15.09	-7.16	18.05	-35.91	-4.56
Capital Expenditures, 1 Yr. Growth %	1.3K	121.43	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-12.8	-59.84	-14.19	54.44	-8.14
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.28	-62.41	1.45	34.28	-12.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	50	-64.3	9.99	-26.62	179.76
Gross Profit, 2 Yr. CAGR %	-23.3	-31.04	34.16	-82.85	298.26
EBITDA, 2 Yr. CAGR %	60.55	79.69	20.85	-20.59	-6.62
EBITA, 2 Yr. CAGR %	58.77	78	20.98	-20.47	-6.58
EBIT, 2 Yr. CAGR %	58.77	78	20.98	-20.47	-6.58
Earnings From Cont. Operations, 2 Yr. CAGR %	3.81	294.45	29.83	-25.38	-4.29
Net Income, 2 Yr. CAGR %	3.81	294.45	29.83	-25.38	-4.29
Normalized Net Income, 2 Yr. CAGR %	17.41	1.41K	17.97	-19.87	-3.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.11	95.55	-36.4	-42.83	-23.82
Accounts Receivable, 2 Yr. CAGR %	88.11	-50	-60.99	-29.29	-24.41
Inventory, 2 Yr. CAGR %	244.9	-4.83	5.21	7.48	-15.81
Net Property, Plant and Equip., 2 Yr. CAGR %	71	-12.83	-18.09	-31.05	64.63
Total Assets, 2 Yr. CAGR %	31.48	57.9	-9.55	-36.02	-10.93
Tangible Book Value, 2 Yr. CAGR %	-16.68	-33.72	-25.55	15	5.68
Common Equity, 2 Yr. CAGR %	-16.68	-33.72	-25.55	15	5.68
Cash From Operations, 2 Yr. CAGR %	40.54	-11.22	4.72	-13.02	-21.79
Capital Expenditures, 2 Yr. CAGR %	-	456.78	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	132.39	-32.49	-41.3	-24.21	17.57
Unlevered Free Cash Flow, 2 Yr. CAGR %	155.68	-37.23	-38.25	-25.52	8.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.43	-28.79	-1.32	-55.79	289.3
Gross Profit, 3 Yr. CAGR %	-14.5	25.99	-36.86	-53.58	103.26
EBITDA, 3 Yr. CAGR %	15.79	53.75	49.54	-3.84	-10.81
EBITA, 3 Yr. CAGR %	15.12	52.65	48.67	-3.72	-10.72
EBIT, 3 Yr. CAGR %	15.12	52.65	48.67	-3.72	-10.72
Earnings From Cont. Operations, 3 Yr. CAGR %	26.77	31.23	132.11	5.3	-9.7
Net Income, 3 Yr. CAGR %	26.77	31.23	132.11	5.3	-9.7
Normalized Net Income, 3 Yr. CAGR %	386.48	26.32	500.71	-2.08	-10.68
Diluted EPS Before Extra, 3 Yr. CAGR %	136.15	-35.94	22.49	-34.96	-34.66
Accounts Receivable, 3 Yr. CAGR %	52.38	-22.72	-33.68	-59.75	-12.64
Inventory, 3 Yr. CAGR %	71.1	125.17	1.47	3.5	-6.5
Net Property, Plant and Equip., 3 Yr. CAGR %	163.91	37.75	-17.06	-24.82	26.72
Total Assets, 3 Yr. CAGR %	105.23	41.82	7.33	-12.26	-26.73
Tangible Book Value, 3 Yr. CAGR %	-9.53	-30.47	-20.48	-13.8	8.53
Common Equity, 3 Yr. CAGR %	-9.53	-30.47	-20.48	-13.8	8.53
Cash From Operations, 3 Yr. CAGR %	5.26	22.4	-2.35	-11.09	-10.28
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-59.89
Levered Free Cash Flow, 3 Yr. CAGR %	2.74	41.32	-26.87	-38.67	-19.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.89	49.73	-26.34	-40.7	-21.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-33.11	-44.37	11.45	-27.93	49.71
Gross Profit, 5 Yr. CAGR %	-29.15	-24.97	2.38	-43.26	31.9
EBITDA, 5 Yr. CAGR %	-1.89	2.74	17.78	18.04	18.03
EBITA, 5 Yr. CAGR %	-9.17	1.32	17.43	17.61	17.66
EBIT, 5 Yr. CAGR %	-9.17	1.32	17.43	17.61	17.66
Earnings From Cont. Operations, 5 Yr. CAGR %	-12.21	-16.5	27.99	4.7	62.85
Net Income, 5 Yr. CAGR %	-12.21	-16.5	27.99	4.7	62.85
Normalized Net Income, 5 Yr. CAGR %	-7.78	-18.39	176.02	5.29	176.73
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-82.74	39.73	-38.79	1.3
Accounts Receivable, 5 Yr. CAGR %	-	14.87	-11.65	-25.42	-30.12
Inventory, 5 Yr. CAGR %	-5.88	24.66	40.85	67.51	-5.83
Net Property, Plant and Equip., 5 Yr. CAGR %	25.1	47.75	65.28	4.44	9.11
Total Assets, 5 Yr. CAGR %	6.46	52.66	47.88	3.15	-0.39
Tangible Book Value, 5 Yr. CAGR %	3.11	-21.85	-16.31	-14.96	-10.9
Common Equity, 5 Yr. CAGR %	3.11	-21.85	-16.31	-14.96	-10.9
Cash From Operations, 5 Yr. CAGR %	-2.45	5.26	5.05	6.78	-10.65
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	14.87
Levered Free Cash Flow, 5 Yr. CAGR %	69.16	34.05	-13.43	10.14	-25.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.18	-0.55	-11.76	13.24	-28.22